Cancer Drug Design Company Associated with Longtime NFCR Support Attracts New Investment

Rasio Therapeutics, a company whose cancer drug research technology was developed and applied in part with funding provided over many years by the National Foundation for Cancer Research to University of Maryland, Baltimore, researcher Curt Civin, has raised additional investment…

Read more

NFCR CMO Brian Leyland-Jones Featured in Pancreatic Cancer Risk Overview

Insights from National Foundation for Cancer Research Chief Medical Officer Brian Leyland-Jones, along with such other authoritative sources as Johns Hopkins Medicine, the Mayo Clinic and the U.S. National Cancer Institute, are featured in this Eat This, Not That! overview…

Read more

National Foundation for Cancer Research Announces 2021 Salisbury Award Competition Winners

FOR IMMEDIATE RELEASE: May 25, 2021 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of…

Read more

Interview with NFCR CEO Sujuan Ba Featured in BioBuzz—a Popular Regional Industry News Source

5 Questions With…” is a weekly BioBuzz series where interesting people share a little about themselves, their work and maybe something completely unrelated. This week the series features Dr. Sujuan Ba, president and chief executive officer of the National Foundation…

Read more

Applications Open for the National Foundation for Cancer Research’s Salisbury Award Competition for Entrepreneurial Translational Cancer Research

FOR IMMEDIATE RELEASE: December 3, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of…

Read more

Understanding the Role of Physical Traits of Cancer on Tumor Growth

To better understand tumor initiation and growth, National Foundation for Cancer Research (NFCR) Fellow Dr. Rakesh Jain and colleagues continue to investigate the role of the physical microenvironment surrounding cancer cells. When a tumor is growing, the tissues that surround…

Read more

DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083’s Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research

SAN DIEGO, June 24, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today it has received a $500,000 loan from the National…

Read more

First-in-Class Drug Candidate Developed Through National Foundation for Cancer Research Funding Commences International Phase IIB Liver Cancer Clinical Trial

FOR IMMEDIATE RELEASE: May 19, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng…

Read more

NFCR Takes Steps to Address Cancer Community Needs During Coronavirus Pandemic

FOR IMMEDIATE RELEASE: April 14, 2020                                                  CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD –The National Foundation for Cancer Research (NFCR) has launched an online resource center…

Read more

Free Cancer Screening Guidelines

DOWNLOAD